Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

191.18
Delayed Data
As of Dec 05
 +1.49 / +0.79%
Today’s Change
184.50
Today|||52-Week Range
317.48
-38.82%
Year-to-Date
Amgen/Allergan File for EU Approval of Avastin Biosimilar
Dec 05 / Zacks.com - Paid Partner Content
Stock Futures Hold Lower After U.S. Adds 178,000 Jobs
Dec 02 / TheStreet.com - Paid Partner Content
Week in Review, December 2
Dec 02 / FT.com - Paid Partner Content
The Deal Economy Event Is Live
Dec 01 / TheStreet.com - Paid Partner Content
Oaktree Reduces, Eliminates Multiple Positions in the 3rd Quarter
Dec 02 / GuruFocus News - Paid Partner Content
Valeant's talks to sell Salix unit for $10bn break down
Nov 30 / FT.com - Paid Partner Content
Stocks Mixed as November Jobs Solidify Chances of December Rate Hike
Dec 02 / TheStreet.com - Paid Partner Content
Teva Is a Hold
Nov 30 / GuruFocus News - Paid Partner Content
Biotechs Look Dangerous Again As Trump Rally Fades
Dec 02 / Investing Channel - Paid Partner Content
Allergan Seeks to Reassure Antsy Investors but Will They Buy It?
Nov 30 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close189.69
Today’s open190.06
Day’s range189.46 - 192.07
Volume4,295,318
Average volume (3 months)4,234,182
Market cap$71.1B
Dividend yield1.46%
Data as of 4:02pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+0.14%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales7.63
Price/Book1.04

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-0.45-0.66%
NVONovo Nordisk+0.49+1.44%
AZNAstraZeneca-0.07-0.27%
ABTAbbott Laboratories+0.53+1.40%
Data as of 4:02pm ET, 12/05/2016

Financials

Next reporting dateFebruary 21, 2017
EPS forecast (this quarter)$3.74
Annual revenue (last year)$15.1B
Annual profit (last year)$3.9B
Net profit margin-19.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs